Mesoporous bioactive glass nanoparticles with biomineralization activity for surgical hemorrhage control

Shengyu Li,Xijin Wu,Jianglin Chen,Jinwei Wang,Lihong Gong,Jianyu Ni,Saifei Xi,Hong Zhang,Huiying Fu,Qiyang Shou
DOI: https://doi.org/10.1080/14686996.2023.2279030
IF: 7.821
2023-12-07
Science and Technology of Advanced Materials
Abstract:Bioactive glass nanoparticles (BGNs) are good bioactive materials for clinical treatment because of their unique composition and silica-oxygen network structure. Herein, we designed and reported a monodisperse mesoporous bioactive glass nanoparticle with biomineralization activity for surgical hemorrhage control. The results indicated that the BGNs have excellent biomineralization ability. In vivo and in vitro hemostasis studies suggested that BGNs have superior hemostatic properties to GZ (gauze) and GS (commercial gelatin sponge) and validated in vitro thrombosis, platelet adhesion, cytocompatibility and blood compatibility. The particles activated both endogenous and exogenous physiological coagulation pathways and could activate platelets and release Ca 2+ to participate in the clotting pathway. Besides, the BGNs have good biocompatibility in vivo. These findings demonstrated that the potential of small diameter mesoporous bioactive glass nanoparticles is likely useful for bleeding control as potential hemostatic agents. Monodisperse mesoporous bioactive glass nanoparticles about 100 nm have excellent biomineralization ability, histocompatibility and hemostatic capacity, which could active endogenous and exogenous coagulation pathways and release Ca 2+ to participate in.
materials science, multidisciplinary
What problem does this paper attempt to address?